MORGAN HEMER: Open Payments
NPI 1558986257 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,824 in 121 payments from 14 companies in 2025. Trend: 2023 $1,198 · 2024 $1,529 · 2025 $1,824
Food & beverage: $1,824
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $482 |
| Janssen Biotech, Inc. | 16 | $306 |
| Lilly USA, LLC | 16 | $267 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $252 |
| Celltrion USA Inc. | 7 | $113 |
| Ipsen Biopharmaceuticals, Inc | 4 | $112 |
| Phathom Pharmaceuticals, Inc. | 8 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Gilead Sciences, Inc. | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $24 |
Products named: TREMFYA, RINVOQ, OMVOH, SKYRIZI, ENTYVIO, VEGZELMA, IQIRVO, EOHILIA.
Industry payments across IA — which companies pay providers there.
